TLR4 and breast carcinoma: Long et al. found that AT-I could suppress cell proliferation, migration, and invasion and induce apoptosis of breast cancer cells by inhibiting the TLR4/NF-κB signaling pathway, ameliorating breast cancer tumorigenesis [47].